je.st
news
CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research
2016-02-21 21:23:01| Biotech - Topix.net
's stock had its "buy" rating reissued by Zacks Investment Research in a research note issued on Sunday, MarketBeat Ratings reports. They currently have a $20.00 price target on the stock.
Tags: buy
research
rating
investment
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||